» Authors » Jason B Samarasena

Jason B Samarasena

Explore the profile of Jason B Samarasena including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 672
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dang F, Samarasena J
Am J Gastroenterol . 2023 Nov; 118(12):2146-2147. PMID: 38033225
No abstract available.
2.
Chang K, Samarasena J
Gastrointest Endosc Clin N Am . 2023 Nov; 34(1):xv-xviii. PMID: 37973235
No abstract available.
3.
Tavangar A, Samarasena J
Gastrointest Endosc Clin N Am . 2023 Nov; 34(1):179-187. PMID: 37973228
The diagnosis and management of pancreatic cancer has become a standard role for the endoscopic oncologist. Pancreatic cancer can produce disabling abdominal pain, and the medical management of this pain...
4.
Shah S, El Hage Chehade N, Tavangar A, Choi A, Monachese M, Chang K, et al.
Clin Endosc . 2023 Feb; 56(1):38-49. PMID: 36733989
Background/aims: Patients with Barrett's esophagus are at increased risk of developing esophageal adenocarcinoma. Endoscopic therapies aim to eradicate dysplastic and metaplastic tissues. Hybrid argon plasma coagulation (hybrid-APC) utilizes submucosal fluid...
5.
El Hage Chehade N, Ghoneim S, Shah S, Chahine A, Issak A, Choi A, et al.
Dig Dis Sci . 2022 Jun; 68(3):957-968. PMID: 35695971
Background: The utility of combination rectal NSAID and topical epinephrine (EI) or rectal NSAID and normal saline (SI) sprayed on duodenal papilla in the prevention of post-ERCP pancreatitis (PEP) has...
6.
Dayyani F, Smith B, Nguyen N, Daly S, Hinojosa M, Seyedin S, et al.
Future Oncol . 2022 May; 18(21):2615-2622. PMID: 35603628
Current guidelines recommend neoadjuvant (NAC) and/or adjuvant chemotherapy for locally advanced gastric cancers (LAGCs). However, the choice and duration of NAC regimen is standardized, rather than personalized to biologic response,...
7.
Choi A, Kolb J, Shah S, Chahine A, Hashimoto R, Patel A, et al.
J Gastroenterol Hepatol . 2022 May; 37(7):1373-1379. PMID: 35513894
Background And Aim: The portal pressure gradient (PPG) is a useful predictor of portal hypertension (PH) related complications. We previously showed the feasibility and safety of endoscopic ultrasound guided PPG...
8.
Choi A, Chang K, Samarasena J, Lee J, Li X, Guo W, et al.
Dig Dis Sci . 2022 Mar; 67(12):5685-5692. PMID: 35279787
Background And Aims: Endoscopic ultrasound is a novel diagnostic approach to chronic liver diseases (CLDs), and EUS-guided porto-systemic pressure gradient measurement (EUS-PPG) is an important expansion with a well-developed technique....
9.
Cho M, Gholami S, Gui D, Tejaswi S, Fananapazir G, Abi-Jaoudeh N, et al.
Cancers (Basel) . 2022 Jan; 14(2). PMID: 35053557
Cholangiocarcinoma (CCA) is a heterogenous group of malignancies originating in the biliary tree, and associated with poor prognosis. Until recently, treatment options have been limited to surgical resection, liver-directed therapies,...
10.
Shimizu T, Samarasena J, Fortinsky K, Hashimoto R, El Hage Chehade N, Chin M, et al.
Endosc Int Open . 2021 Dec; 9(12):E1870-E1876. PMID: 34917455
A novel technique for Barrett's esophagus (BE) ablation, termed hybrid APC, has recently been developed. The aims of this US pilot study were to evaluate the efficacy, tolerance and safety...